Clinical outcome of Crohn's disease treated with infliximab
HEPATO-GASTROENTEROLOGY, vol.50, no.52, pp.952-956, 2003 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 50 Issue: 52
- Publication Date: 2003
- Journal Name: HEPATO-GASTROENTEROLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.952-956
- Hacettepe University Affiliated: No
Abstract
Background/Aims: Controlled studies in humans have shown the role of antibodies to tumor necrosis factor-alpha in the treatment of both fistulizing and inflammatory Crohn's disease. The aim of this study is to report the results of a multicenter clinical trial to evaluate efficacy of infliximab in Crohn's disease patients who are refractory to conservative drugs or fistulizing Crohn's disease.